Researchers at Nano Life Science Institute of Kanazawa University in Japan, have discovered how a protein called 'lamin A' ...

Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and ...

Broadway at the Eccles brings the touring production of Kimberly Akimbo to the Eccles Theater (131 S. Main St.) Dec. 10 – 15, ...

In the U.S., about 30 million people—half of them children—have a rare disease, according to the U.S. Government ...

Telomir Pharmaceuticals (NASDAQ: TELO) has announced groundbreaking preclinical findings suggesting that its licensed molecule, Telomir-1, can reverse key Type 2 diabetes parameters. As a leader in ...

Nov. 22, 2024 — A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based ...